AF
FNCH

Amalgamated Financial’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Amalgamated Financial’s Portfolio FNCH Stock Details FNCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$5K Buy
+31
New +$7.15K ﹤0.01% 2966

Other funds holding FNCH

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
TA
TRB Advisors New York $146M AUM 3.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Amalgamated Financial's FNCH Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q1 2022: 31 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #2966 among its holdings.

53 funds tracked by Wall St. Rank hold FNCH as of Q1 2022.

  • Amalgamated Financial held 31 shares of Finch Therapeutics Group, Inc. Common Stock worth $5K as of Q1 2022.
  • Finch Therapeutics Group, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
  • Finch Therapeutics Group, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2966 holding.
  • 53 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.